Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 161,669 | 53,428 | 60,081 | 64,593 | 115,684 |
| Marketable Securities | 157,461 | 147,771 | 215,765 | 234,667 | 137,918 |
| Receivables | 17,598 | 14,695 | 14,867 | 14,541 | 13,831 |
| Inventories | 11,994 | 8,507 | 8,624 | 7,762 | 6,178 |
| TOTAL | $357,366 | $235,753 | $308,268 | $329,201 | $283,878 |
| Non-Current Assets | |||||
| PPE Net | 973 | 1,149 | 1,341 | 1,545 | 1,773 |
| Intangibles | 6,601 | 6,815 | 7,028 | 7,242 | 7,456 |
| Other Non-Current Assets | 16,906 | 14,934 | 16,108 | 16,211 | 16,836 |
| TOTAL | $24,480 | $22,898 | $24,477 | $24,998 | $26,065 |
| Total Assets | $381,846 | $258,651 | $332,745 | $354,199 | $309,943 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,543 | 7,550 | 4,885 | 3,839 | 8,383 |
| Accrued Expenses | 48,077 | 44,531 | 48,262 | 44,271 | 35,708 |
| TOTAL | $54,722 | $54,160 | $55,203 | $50,144 | $46,103 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,286 | 1,286 | 1,286 | 1,286 | 1,286 |
| Other Non-Current Liabilities | 39,257 | 35,542 | 1,640 | 1,882 | 2,208 |
| TOTAL | $147,629 | $142,910 | $107,783 | $106,581 | $81,555 |
| Total Liabilities | $202,351 | $197,070 | $162,986 | $156,725 | $127,658 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,134 | 60,973 | 60,141 | 59,096 | 56,902 |
| Common Shares | 60 | 60 | 59 | 59 | 57 |
| Retained earnings | -1,068,369 | -1,036,108 | -894,736 | -853,103 | -808,940 |
| Other shareholders' equity | 139,535 | -181 | 134 | -113 | -14 |
| TOTAL | $179,495 | $61,581 | $169,759 | $197,474 | $182,285 |
| Total Liabilities And Equity | $381,846 | $258,651 | $332,745 | $354,199 | $309,943 |